MedPath

Aeon Astron Europe B.V.

๐Ÿ‡ณ๐Ÿ‡ฑNetherlands
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 4:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
2 (66.7%)
Phase 4
1 (33.3%)

Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery

Phase 4
Completed
Conditions
Glaucoma
Interventions
Device: Use of ologen Collagen Matrix in trabeculectomy (ologen)
Drug: Use of Mitomycin-C (MMC) in trabeculectomy
First Posted Date
2011-09-27
Last Posted Date
2017-11-01
Lead Sponsor
Aeon Astron Europe B.V.
Target Recruit Count
99
Registration Number
NCT01440751
Locations
๐Ÿ‡บ๐Ÿ‡ธ

VoldVision-Holf Eye Clinic, Rogers, Arkansas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Northwestern Memorial Hospital, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Institue of Ophthalmology and Visual Science, Newark, New Jersey, United States

and more 5 locations

Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany

Not Applicable
Conditions
Open-angle Glaucoma
Interventions
Device: Use of ologen Collagen Matrix in trabeculectomy
Drug: Use of Mitomycin-C in trabeculectomy
First Posted Date
2010-08-03
Last Posted Date
2011-05-09
Lead Sponsor
Aeon Astron Europe B.V.
Target Recruit Count
40
Registration Number
NCT01174420
Locations
๐Ÿ‡ฉ๐Ÿ‡ช

The University Hospital of Cologne, Cologne, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.